MedPath

Clinical and Radiographic Assessment of a Novel Wedge Shape Implant Placed in Edentulous Narrow Ridges

Not Applicable
Completed
Conditions
Implant Surface
Surgical Technique
Interventions
Procedure: Bone Consumption
Procedure: Bone expansion
Registration Number
NCT06178536
Lead Sponsor
Christian Makary
Brief Summary

The aim is to clinically and radiographically assess a novel wedge implant placed in narrow ridges.

* 60 wedge implants (Rex Implants, Columbus, OH, USA) will be placed using Piezosurgery® following either a bone consumption (n=30) or bone expansion technique (n=30). Each group (bone consumption and bone expansion) will be divided into 2 surface treatments: machined transcortical portion (n=15) and roughened transcortical portion (n=15).

* Record the time needed to place each implant.

* ISQ will be evaluated at Day 0, 3 weeks, 6 weeks, 3 months, 4 months, and 6 months after implant placement.

* Periapical radiographs will be performed at implant placement, loading. and 1, 3, and 5 years after loading to assess marginal bone stability.

* Buccal bone height and lingual and buccal bone thickness will be recorded post-intervention, at the time of functional loading, and at 12, 36, and 60 months after loading with CBCT.

* Digital impressions will be taken post-operatively, at loading and at 12 months after loading to monitor gingival profile.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
18
Inclusion Criteria
  1. Partially or totally edentulous patients presenting indications for a prosthetic rehabilitation supported by the upper or lower jaw implants on the basis of an accurate diagnosis and treatment planning;
  2. the bone crest must be completely healed (at least six months after the loss of teeth);
  3. the residual bone crest must have a width between 3 and 5 mm;
  4. presence of at least 10 mm of bone height available for implant placement; 5) patient age > 18 years;
  1. the patient must not wear any type of removable dentures on the treated area; 7) the patient must be capable of following the study protocol; and 8) written informed consent must be provided
Exclusion Criteria
  1. acute myocardial infarction within the last two months;
  2. Uncontrolled coagulation disorders;
  3. uncontrolled diabetes (HBA1c> 7.5);
  4. radiation therapy to the head \ neck region in the last 24 months;
  5. immunocompromised patients, HIV positive or receiving chemotherapy in the last five years;
  6. past or present treatment with intravenous bisphosphonates;
  7. psychological or psychiatric problems;
  8. abuse of alcohol or drugs;

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Rex implant machined transcortical portionBone ConsumptionImplants in these group will have a machined portion at the neck of the implant
Rex implant machined transcortical portionBone expansionImplants in these group will have a machined portion at the neck of the implant
Rex implant roughened transcortical portionBone ConsumptionRex implants with a rough surface until the neck of the implant
Rex implant roughened transcortical portionBone expansionRex implants with a rough surface until the neck of the implant
Primary Outcome Measures
NameTimeMethod
Implant stability0, 3 weeks, 6 weeks, 3 months, 4 months, and 6 months after implant placement.

Implant stability quotient evaluation

Bone stabilityAt 6 months, and at 12, 36, and 60 months after loading

Periapical radiograph and CBCT

Gingival profile monitoringDay 0 of surgery, at 6 months and at 12 months.

Digital impression superimposition

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Saint Joseph University

🇱🇧

Beirut, Lebanon

© Copyright 2025. All Rights Reserved by MedPath